Literature DB >> 1894634

Adenylate cyclase toxin from Bordetella pertussis. Conformational change associated with toxin activity.

E L Hewlett1, L Gray, M Allietta, I Ehrmann, V M Gordon, M C Gray.   

Abstract

Adenylate cyclase (AC) toxin from Bordetella pertussis interacts with and enters eukaryotic cells to catalyze the production of supraphysiologic levels of cyclic AMP. Although the calmodulin-activated enzymatic activity (ability to convert ATP to cyclic AMP in a cell-free assay) of this molecule is calcium independent, its toxin activity (ability to increase cyclic AMP levels in intact target cells) requires extracellular calcium. Toxin activity as a function of calcium concentration is biphasic, with no intoxication occurring in the absence of calcium, low level intoxication (200-300 pmol of cyclic AMP/mg of Jurkat cell protein) occurring with free calcium concentrations between 100 nM and 100 microM and a 10-fold increase in AC toxin activity at free calcium concentrations above 300 microM. The molecule exhibits a conformational change when free calcium concentrations exceed 100 microM as demonstrated by shift in intrinsic tryptophan fluorescence, an alteration in binding of one anti-AC monoclonal antibody, protection of a fragment from trypsin-mediated proteolysis, and a structural modification as illustrated by electron microscopy. Thus, it appears that an increase in the ambient calcium concentration to a critical point and the ensuing interaction of the toxin with calcium induces a conformational change which is necessary for its insertion into the target cell and for delivery of its catalytic domain to the cell interior.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.

Authors:  R Osicka; A Osicková; T Basar; P Guermonprez; M Rojas; C Leclerc; P Sebo
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.

Authors:  Jiri Masin; Radim Osicka; Ladislav Bumba; Peter Sebo
Journal:  Pathog Dis       Date:  2015-09-20       Impact factor: 3.166

4.  Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.

Authors:  Fabiana Spensieri; Giorgio Fedele; Cecilia Fazio; Maria Nasso; Paola Stefanelli; Paola Mastrantonio; Clara Maria Ausiello
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Bordetella adenylate cyclase toxin promotes calcium entry into both CD11b+ and CD11b- cells through cAMP-dependent L-type-like calcium channels.

Authors:  César Martín; Geraxane Gómez-Bilbao; Helena Ostolaza
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

6.  Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.

Authors:  M C Gray; W Ross; K Kim; E L Hewlett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the adenylyl cyclase domain.

Authors:  Jana Holubova; Jana Kamanova; Jiri Jelinek; Jakub Tomala; Jiri Masin; Martina Kosova; Ondrej Stanek; Ladislav Bumba; Jaroslav Michalek; Marek Kovar; Peter Sebo
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

8.  Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7.

Authors:  M E Bauer; R A Welch
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Analysis of toxinogenic functions associated with the RTX repeat region and monoclonal antibody D12 epitope of Escherichia coli hemolysin.

Authors:  G E Rowe; S Pellett; R A Welch
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways.

Authors:  Giorgio Fedele; Fabiana Spensieri; Raffaella Palazzo; Maria Nasso; Gordon Yiu Chong Cheung; John Graham Coote; Clara Maria Ausiello
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.